Biocon Biologics introduces Hulio a Humira biosimilar for rheumatoid arthritis in US

Biocon Biologics introduces Hulio, a Humira biosimilar for rheumatoid arthritis, in US The drug has been made available to patients in the United States after five years of experience in Europe and two years in Canada, the release said.

from Moneycontrol Business News https://ift.tt/xWe4LTR

No comments:

Post a Comment

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...